User contributions for CMensger
15 August 2024
- 08:5508:55, 15 August 2024 diff hist −545 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
8 August 2024
- 11:0511:05, 8 August 2024 diff hist +149 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 10:5610:56, 8 August 2024 diff hist +545 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 10:4510:45, 8 August 2024 diff hist +1,216 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 10:2210:22, 8 August 2024 diff hist +1 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 10:2110:21, 8 August 2024 diff hist +1 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 10:2010:20, 8 August 2024 diff hist −665 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 10:1810:18, 8 August 2024 diff hist +698 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 10:1510:15, 8 August 2024 diff hist +907 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 10:0510:05, 8 August 2024 diff hist +14 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 09:5909:59, 8 August 2024 diff hist +32 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 09:5409:54, 8 August 2024 diff hist +57 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 09:1709:17, 8 August 2024 diff hist +20 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
11 July 2024
- 11:5011:50, 11 July 2024 diff hist +226 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 11:4811:48, 11 July 2024 diff hist +383 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 11:2311:23, 11 July 2024 diff hist +559 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 10:5710:57, 11 July 2024 diff hist +336 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 10:0610:06, 11 July 2024 diff hist +15 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 10:0310:03, 11 July 2024 diff hist +377 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 09:5209:52, 11 July 2024 diff hist +1 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 09:4709:47, 11 July 2024 diff hist −4 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 09:4509:45, 11 July 2024 diff hist +161 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 08:2808:28, 11 July 2024 diff hist +86 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 08:1308:13, 11 July 2024 diff hist +401 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 08:0808:08, 11 July 2024 diff hist +156 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 07:5807:58, 11 July 2024 diff hist +694 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 07:4607:46, 11 July 2024 diff hist +13 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
- 07:3807:38, 11 July 2024 diff hist +23 Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics No edit summary
20 June 2024
- 07:3507:35, 20 June 2024 diff hist +10 N Gescher, AJ Created page with "{{Author}}" current
- 07:3507:35, 20 June 2024 diff hist +10 N Steward, WP Created page with "{{Author}}" current
- 07:3407:34, 20 June 2024 diff hist +10 N Brown, K Created page with "{{Author}}" current
- 07:3407:34, 20 June 2024 diff hist +10 N Hegarty, B Created page with "{{Author}}" current
- 07:3407:34, 20 June 2024 diff hist +10 N Hoffmann, E Created page with "{{Author}}" current
- 07:3307:33, 20 June 2024 diff hist +10 N Jacobson, EW Created page with "{{Author}}" current
- 07:3307:33, 20 June 2024 diff hist +10 N Elliott, PJ Created page with "{{Author}}" current
- 07:3307:33, 20 June 2024 diff hist +10 N Berry, DP Created page with "{{Author}}" current
- 07:3207:32, 20 June 2024 diff hist +10 N Howells, LM Created page with "{{Author}}" current
13 June 2024
- 08:2708:27, 13 June 2024 diff hist +1,745 N Publication: Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics Created page with "{{Publication |Title=Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics |Topic=Resveratrol |Author=Howells, LM; Berry, DP; Elliott, PJ; Jacobson, EW; Hoffmann, E; Hegarty, B; Brown, K; Steward, WP; Gescher, AJ |Year=2011 |Journal=Cancer Prevention Research |DOI=10.1158/1940-6207.CAPR-11-0148 |Authors Abstract=The phytochemical resveratrol has undergone extensiv..." current